Skip to main content
Equibles

BAKER BROS. ADVISORS LP

Position in IMVT — Immunovant, Inc.

CIK 1263508 NEW YORK, NY
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$209,419,026
+$73,845,262 QoQ
Shares Held
5,435,220
-0.4% QoQ
Ownership
2.63%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#5
of 226 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. IMVT ranks #14 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 30,762,330 $3,487,217,728
2 ONC
BeOne Medicines Ltd.
 8,801,567 $2,508,182,547
3 RVMD
Revolution Medicines, Inc.
 11,443,357 $2,143,111,898
4 MDGL
Madrigal Pharmaceuticals, Inc.
 2,143,131 $1,150,754,190
5 ACAD
Acadia Pharmaceuticals Inc
 42,912,904 $1,085,696,471
6 KYMR
Kymera Therapeutics, Inc.
 8,657,242 $992,725,940
7 INSM
INSMED Inc
 8,796,111 $937,841,354
8 CELC
Celcuity Inc.
 7,915,792 $828,150,159

All Filings in IMVT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $209,419,026 5,435,220
2026-03-31 $135,573,764 5,457,881
2025-12-31 $138,739,335 5,457,881
2025-09-30 $87,981,041 5,457,881
2025-06-30 $87,326,096 5,457,881
2025-03-31 $93,275,186 5,457,881
2024-12-31 $42,304,212 1,707,881
2024-09-30 $34,936,439 1,225,410
2024-06-30 $12,268,555 464,718
2024-03-31 $13,732,040 425,009
2023-12-31 $17,905,629 425,009
2023-09-30 $16,316,095 425,009